Document is current
Any future updates will be listed below
-
Authors
Sacu, Seda https://orcid.org/0000-0003-4734-9835
Hermann, Andrea
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Gerchen, Martin F. https://orcid.org/0000-0003-3071-5296
Holz, Nathalie E. https://orcid.org/0000-0002-6225-9267
- License Information
-
More Information
Article History
Received: 19 July 2024
Revised: 25 March 2025
Accepted: 3 April 2025
First Online: 18 April 2025
Competing interests
: TB served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Janssen, Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. The present work is unrelated to the above grants and relationships. All other authors report no biomedical financial interests or potential conflicts of interest.
